[EN] DI-VANILLOYL AND TRI-VANILLOYL DERIVATIVES FOR USE IN ANTI-CANCER THERAPY<br/>[FR] DÉRIVÉS DE DI-VANILLOYLE ET DE TRI-VANILLOYLE POUR UNE UTILISATION DANS UNE THÉRAPIE ANTI-CANCÉREUSE
申请人:UNIV BRUXELLES
公开号:WO2010043631A1
公开(公告)日:2010-04-22
The invention relates to the medical field, more precisely in the field of anti-cancer treatment and treatment of Alzheimer's disease, Parkinson's disease or Pick's disease or for ameliorating symptoms of Down syndrome, providing newly synthesised multi-vanilloyl derivative compounds and their use in the treatment of said disorders.
Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals
申请人:——
公开号:US20040122069A1
公开(公告)日:2004-06-24
Diarylcycloalkyl derivatives and their physiologically acceptable salts and physiologically functional derivatives are disclosed. The compounds include those of formula I,
1
in which the radicals are as defined, and their physiologically acceptable salts and processes for their preparation. The compounds typically have lipid- and/or triglyceride-lowering properties and are suitable, for example, for the treatment of disorders of lipid metabolism, of type II diabetes, and of syndrome X.
Diarylcycloalkyl derivatives, processes for their preparation and their use s pharmaceuticals
申请人:——
公开号:US20030144332A1
公开(公告)日:2003-07-31
Diarylcycloalkyl derivatives and their physiologically acceptable salts and physiologically functional derivatives are disclosed. The compounds include those of formula I,
1
in which the radicals are as defined, and their physiologically acceptable salts and processes for their preparation. The compounds typically have lipid- and/or triglyceride-lowering properties and are suitable, for example, for the treatment of disorders of lipid metabolism, of type II diabetes, and of syndrome X.
披萨店的员工们正在忙着准备今晚的外卖订单。
Method for producing 1,3-cyclohexanediol compound
申请人:MITSUBISHI CHEMICAL CORPORATION
公开号:US20030149293A1
公开(公告)日:2003-08-07
A method for producing 1,3-cyclohexanediol compounds, particularly a 1,3-cyclohexanediol compound rich in cis-form. A 1,3-cyclohexanediol compound is reduced with a boron hydride compound such as sodium borohydride. Selectivity of cis-form is improved when an alkali metal compound and/or an alkaline earth metal compound, particularly a halide, is allowed to exist in the reaction system.
Copolymers, as well as compounds, compositions, articles of manufacture, and methods of making thereof, are disclosed. The copolymers may generally exhibit flexibility properties and may generally have a high refractive index. The copolymers may generally be made by providing a dihydrodisiloxane and an aliphatic vinyl alcohol and combining the dihydrodisiloxane and the aliphatic vinyl alcohol under conditions that allow for hydrogenation of the aliphatic vinyl alcohol and result in coupling of the aliphatic vinyl alcohol to the dihydrodisiloxane to produce a hydroxyl substituted siloxane.